Lixte - Ownership and Business Overview

Life ScienceCompany

Lixte Ownership

Who owns Lixte?

.

Lixte Business Overview

Where is Lixte headquartered?

Lixte is headquartered in Pasadena, California.

What is Lixte’s revenue?

Lixte disclosed revenue of 5M USD for 2023 and 6M USD for 2022.

How many employees does Lixte have?

Lixte has 3 employees.

What sector is Lixte in?

Lixte is a life science company.

When was Lixte founded?

Lixte was founded in 2005.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Lixte

Lixte Biotechnology Holdings, Inc.

680 East Colorado Boulevard Suite 180,
Pasadena, California 91101
United States,
(631) 830-7092
www.lixte.com

Lixte is a drug discovery company that has a developed unique, proprietary, first-in-class protein phosphatase inhibitor, LB-100, that has potential widespread use as an anti-cancer agent alone and in combination with standard anti-cancer cytotoxic drugs, radiation, and immune checkpoint blockers. The protein phosphatases are ubiquitous enzymes that regulate many signaling networks important to cell growth, division, and death. These enzymes, especially protein phosphatase 2A (PP2A) have long been appreciated as potentially important targets for anti-cancer drugs but, because of their multi-functionality, it has been believed that their inhibition would be too toxic for clinical use. Lixte was founded in 2005 and is based in Pasadena, California.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.